TY - JOUR
T1 - Novel advances in cardiac rehabilitation
T2 - Position paper from the Working Group on Preventive Cardiology and Cardiac Rehabilitation of the Netherlands Society of Cardiology
AU - Vromen, T.
AU - Brouwers, R.W.M.
AU - Jorstad, H.T.
AU - Kraaijenhagen, R.A.
AU - Spee, R.F.
AU - Wittekoek, M.E.
AU - Cramer, M.J.
AU - van Hal, J.M.C.
AU - Hofstra, L.
AU - Kuijpers, P.M.J.C.
AU - de Melker, E.C.
AU - Rodrigo, S.F.
AU - Sunamura, M.
AU - Uszko-Lencer, N.H.M.K.
AU - Kemps, H.M.
N1 - © 2021. The Author(s).
PY - 2021/10
Y1 - 2021/10
N2 - Cardiac rehabilitation (CR) has evolved as an important part of the treatment of patients with cardiovascular disease. However, to date, its full potential is fairly underutilised. This review discusses new developments in CR aimed at improving participation rates and long-term effectiveness in the general cardiac population. It consecutively highlights new or challenging target groups, new delivery modes and new care pathways for CR programmes. These new or challenging target groups include patients with atrial fibrillation, obesity and cardiovascular disease, chronic coronary syndromes, (advanced) chronic heart failure with or without intracardiac devices, women and frail elderly patients. Also, the current evidence regarding cardiac telerehabilitation and loyalty programmes is discussed as new delivery modes for CR. Finally, this paper discusses novel care pathways with the integration of CR in residual risk management and transmural care pathways. These new developments can help to make optimal use of the benefits of CR. Therefore we should seize the opportunities to reshape current CR programmes, broaden their applicability and incorporate them into or combine them with other cardiovascular care programmes/pathways.
AB - Cardiac rehabilitation (CR) has evolved as an important part of the treatment of patients with cardiovascular disease. However, to date, its full potential is fairly underutilised. This review discusses new developments in CR aimed at improving participation rates and long-term effectiveness in the general cardiac population. It consecutively highlights new or challenging target groups, new delivery modes and new care pathways for CR programmes. These new or challenging target groups include patients with atrial fibrillation, obesity and cardiovascular disease, chronic coronary syndromes, (advanced) chronic heart failure with or without intracardiac devices, women and frail elderly patients. Also, the current evidence regarding cardiac telerehabilitation and loyalty programmes is discussed as new delivery modes for CR. Finally, this paper discusses novel care pathways with the integration of CR in residual risk management and transmural care pathways. These new developments can help to make optimal use of the benefits of CR. Therefore we should seize the opportunities to reshape current CR programmes, broaden their applicability and incorporate them into or combine them with other cardiovascular care programmes/pathways.
KW - Cardiac rehabilitation
KW - Secondary prevention
KW - Telerehabilitation
KW - Transmural care
UR - http://www.scopus.com/inward/record.url?scp=85107508094&partnerID=8YFLogxK
U2 - 10.1007/s12471-021-01585-4
DO - 10.1007/s12471-021-01585-4
M3 - Review article
C2 - 34114176
SN - 1568-5888
VL - 29
SP - 479
EP - 485
JO - Netherlands Heart Journal
JF - Netherlands Heart Journal
IS - 10
ER -